Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain wave breakthrough: simple EEG may spot epilepsy

NCT ID NCT07470931

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way to analyze brain wave recordings (EEG) to see if it can tell people with epilepsy from healthy people. Researchers looked at very fast brain waves called high-frequency oscillations. 80 adults took part. The goal was to see if this method could become a useful tool for diagnosing epilepsy without surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

80 people

The number who actually took part.

Started

Mar 2023

Finished

Sep 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults with epilepsy and age- and sex-comparable healthy controls who underwent scalp EEG recording. The control group consisted of individuals referred to the EEG laboratory for syncope differential diagnosis and found suitable for inclusion as controls.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Inclusion Criteria for Epilepsy Group Adults diagnosed with epilepsy Availability of routine awake scalp EEG recording suitable for analysis EEG recorded with the study protocol and technical specifications Inclusion Criteria for Control Group Adults without epilepsy Referred for EEG evaluation in the context of syncope differential diagnosis Scalp EEG recording suitable for analysis Exclusion Criteria: * EEG recordings with inadequate technical quality or excessive artifact burden preventing HFO analysis Individuals not meeting study group definitions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epilepsies are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Saglik Bilimleri University Izmir Faculty of Medicine Department of Neurology

    Izmir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.